Lv11
40 积分 2026-09-01 加入
The shifting global thalassemia burden and lessons from Chineseintegrated control strategy
54分钟前
待确认
Fludarabine, Busulfan, Thiotepa, and Melphalan: A Novel Low‐Toxicity Myeloablative Conditioning Regimen for Haploidentical HSCT in Children and Adolescents Aged ≥7 Years With Transfusion‐Dependent β‐Thalassemia
1小时前
已完结
皖公网安备34019202002308
